• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

孤儿 G 蛋白偶联受体 GPR52 的自激活途径和别构调节的动态见解。

Dynamic Insights into the Self-Activation Pathway and Allosteric Regulation of the Orphan G-Protein-Coupled Receptor GPR52.

机构信息

Faculty of Environmental and Life Sciences, Beijing University of Technology, Beijing 100124, China.

Key Laboratory of Medicinal and Edible Plants Resources Development of Sichuan Education Department, School of Pharmacy, Chengdu University, Chengdu 610106, China.

出版信息

J Chem Inf Model. 2023 Sep 25;63(18):5847-5862. doi: 10.1021/acs.jcim.3c00672. Epub 2023 Aug 31.

DOI:10.1021/acs.jcim.3c00672
PMID:37651308
Abstract

Within over 800 members of G-protein-coupled receptors, there are numerous orphan receptors whose endogenous ligands are largely unknown, providing many opportunities for novel drug discovery. However, the lack of an in-depth understanding of the intrinsic working mechanism for orphan receptors severely limits the related rational drug design. The G-protein-coupled receptor 52 (GPR52) is a unique orphan receptor that constitutively increases cellular 5'-cyclic adenosine monophosphate (cAMP) levels without binding any exogenous agonists and has been identified as a promising therapeutic target for central nervous system disorders. Although recent structural biology studies have provided snapshots of both active and inactive states of GPR52, the mechanism of the conformational transition between these states remains unclear. Here, an acceptable self-activation pathway for GPR52 was proposed through 6 μs Gaussian accelerated molecular dynamics (GaMD) simulations, in which the receptor spontaneously transitions from the active state to that matching the inactive crystal structure. According to the three intermediate states of the receptor obtained by constructing a reweighted potential of mean force, how the allosteric regulation occurs between the extracellular orthosteric binding pocket and the intracellular G-protein-binding site is revealed. Combined with the independent gradient model, several important microswitch residues and the allosteric communication pathway that directly links the two regions are both identified. Transfer entropy calculations not only reveal the complex allosteric signaling within GPR52 but also confirm the unique role of ECL2 in allosteric regulation, which is mutually validated with the results of GaMD simulations. Overall, this work elucidates the allosteric mechanism of GPR52 at the atomic level, providing the most detailed information to date on the self-activation of the orphan receptor.

摘要

在超过 800 种 G 蛋白偶联受体中,存在许多孤儿受体,其内源性配体在很大程度上尚不清楚,这为新药发现提供了许多机会。然而,对孤儿受体内在工作机制缺乏深入了解严重限制了相关的合理药物设计。G 蛋白偶联受体 52(GPR52)是一种独特的孤儿受体,它在不结合任何外源性激动剂的情况下持续增加细胞 5' - 环磷酸腺苷(cAMP)水平,已被确定为治疗中枢神经系统疾病的有前途的治疗靶点。尽管最近的结构生物学研究提供了 GPR52 的活性和非活性状态的快照,但这些状态之间构象转变的机制仍不清楚。在这里,通过 6 μs 高斯加速分子动力学(GaMD)模拟提出了一种可接受的 GPR52 自激活途径,其中受体自发地从活性状态转变为与非活性晶体结构匹配的状态。根据通过构建重加权平均力势能获得的受体的三个中间状态,揭示了细胞外正位结合口袋和细胞内 G 蛋白结合位点之间的变构调节如何发生。结合独立梯度模型,确定了几个重要的微切换残基和直接连接两个区域的变构通讯途径。传递熵计算不仅揭示了 GPR52 内复杂的变构信号,还证实了 ECL2 在变构调节中的独特作用,这与 GaMD 模拟的结果相互验证。总的来说,这项工作在原子水平上阐明了 GPR52 的变构机制,为孤儿受体的自激活提供了迄今为止最详细的信息。

相似文献

1
Dynamic Insights into the Self-Activation Pathway and Allosteric Regulation of the Orphan G-Protein-Coupled Receptor GPR52.孤儿 G 蛋白偶联受体 GPR52 的自激活途径和别构调节的动态见解。
J Chem Inf Model. 2023 Sep 25;63(18):5847-5862. doi: 10.1021/acs.jcim.3c00672. Epub 2023 Aug 31.
2
Structural basis of ligand recognition and self-activation of orphan GPR52.孤儿 GPR52 配体识别和自身激活的结构基础。
Nature. 2020 Mar;579(7797):152-157. doi: 10.1038/s41586-020-2019-0. Epub 2020 Feb 19.
3
Targeted Proteomics Combined with Affinity Mass Spectrometry Analysis Reveals Antagonist E7 Acts As an Intracellular Covalent Ligand of Orphan Receptor GPR52.靶向蛋白质组学结合亲和质谱分析揭示了 E7 作为孤儿受体 GPR52 的细胞内共价配体的作用。
ACS Chem Biol. 2020 Dec 18;15(12):3275-3284. doi: 10.1021/acschembio.0c00867. Epub 2020 Dec 1.
4
Orphan GPR52 as an emerging neurotherapeutic target.孤儿 GPR52 作为一个新兴的神经治疗靶点。
Drug Discov Today. 2024 Apr;29(4):103922. doi: 10.1016/j.drudis.2024.103922. Epub 2024 Feb 20.
5
Revealing the Positive Binding Cooperativity Mechanism between the Orthosteric and the Allosteric Antagonists of CCR2 by Metadynamics and Gaussian Accelerated Molecular Dynamics Simulations.通过元动力学和高斯加速分子动力学模拟揭示 CCR2 变构拮抗剂与变构结合位点正协同作用机制。
ACS Chem Neurosci. 2020 Feb 19;11(4):628-637. doi: 10.1021/acschemneuro.9b00630. Epub 2020 Feb 4.
6
The non-nutritive sweetener sucralose increases β-arrestin signaling at the constitutively active orphan G protein-coupled receptor GPR52.非营养性甜味剂三氯蔗糖增加了组成性激活孤儿 G 蛋白偶联受体 GPR52 的β-arrestin 信号传导。
Can J Physiol Pharmacol. 2024 Feb 1;102(2):116-127. doi: 10.1139/cjpp-2023-0199. Epub 2023 Sep 25.
7
Revealing the graded activation mechanism of neurotensin receptor 1.揭示神经降压素受体 1 的分级激活机制。
Int J Biol Macromol. 2024 Oct;278(Pt 1):134488. doi: 10.1016/j.ijbiomac.2024.134488. Epub 2024 Aug 5.
8
Anatomical transcriptome of G protein-coupled receptors leads to the identification of a novel therapeutic candidate GPR52 for psychiatric disorders.G蛋白偶联受体的解剖转录组学有助于鉴定一种用于治疗精神疾病的新型候选药物GPR52。
PLoS One. 2014 Feb 28;9(2):e90134. doi: 10.1371/journal.pone.0090134. eCollection 2014.
9
GPR52 regulates cAMP in T cells but is dispensable for encephalitogenic responses.GPR52 调节 T 细胞中的 cAMP,但对致脑炎反应不是必需的。
Front Immunol. 2023 Jan 24;13:1113348. doi: 10.3389/fimmu.2022.1113348. eCollection 2022.
10
The full activation mechanism of the adenosine A receptor revealed by GaMD and Su-GaMD simulations.通过 GaMD 和 Su-GaMD 模拟揭示的腺苷 A 受体的完全激活机制。
Proc Natl Acad Sci U S A. 2022 Oct 18;119(42):e2203702119. doi: 10.1073/pnas.2203702119. Epub 2022 Oct 10.

引用本文的文献

1
Exploring orphan GPCRs in neurodegenerative diseases.探索神经退行性疾病中的孤儿G蛋白偶联受体
Front Pharmacol. 2024 Jun 4;15:1394516. doi: 10.3389/fphar.2024.1394516. eCollection 2024.
2
High-throughput virtual screening of potential inhibitors of GPR52 using docking and biased sampling method for Huntington's disease therapy.使用对接和偏向采样方法对亨廷顿舞蹈病治疗中GPR52潜在抑制剂进行高通量虚拟筛选。
Mol Divers. 2024 Oct;28(5):3331-3347. doi: 10.1007/s11030-023-10763-y. Epub 2023 Dec 1.